drugset / Trial / NCT00132613

Trial of Drainage With or Without Bleomycin Instillation for Malignant Pericardial Effusion

NCT00132613

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy of pericardial instillation of bleomycin as a sclerosing agent after pericardial drainage for lung cancer-associated malignant pericardial effusion.

Timeline

Start
1999-08
Primary completion
2006-11
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Bleomycin Unknown

Indications